Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2021

Open Access 01-12-2021 | Research

Label-free proteomics uncovers SMC1A expression is Down-regulated in AUB-E

Authors: Yingxian Jia, Jie Luo, Yibing Lan, Chunming Li, Linjuan Ma, Xiaoming Zhu, Fei Ruan, Jianhong Zhou

Published in: Reproductive Biology and Endocrinology | Issue 1/2021

Login to get access

Abstract

Background

While heavy menstrual bleeding (HMB) is a prevalent symptom among women with abnormal uterine bleeding caused by endometrial disorder (AUB-E) seeking gynecologic care, the primary endometrial disorder remains poorly understood.

Methods

Five human endometrial samples from women with AUB-E and the age-matched healthy women were selected, respectively. Proteins from the samples were analyzed by a linear ion trap (LTQ)-Orbitrap Elite mass spectrometer based label-free proteomic approach. The purpose protein was validated by western blot and immunohistochemistry staining.

Results

A total of 2353 protein groups were quantified under highly stringent criteria with a false discovery rate of < 1% for protein groups, and 291 differentially expressed proteins were significantly changed between the two groups. The results showed that the down-regulation of structural maintenance of chromosomes protein 1A (SMC1A) in AUB-E patients. Next, this change in the glandular epithelial cells was validated by immunohistochemistry.

Conclusion

The results indicated a novel mechanism for the cause of AUB-E, as down-expression SMC1A potentially regulated the cell cycle progression in endometrial glandular epithelium further led to bleeding.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ilavarasi CR, Jyothi GS, Alva NK. Study of the efficacy of Pipelle biopsy technique to diagnose endometrial diseases in abnormal uterine bleeding. J Midlife Health. 2019;10:75–80.PubMedPubMedCentral Ilavarasi CR, Jyothi GS, Alva NK. Study of the efficacy of Pipelle biopsy technique to diagnose endometrial diseases in abnormal uterine bleeding. J Midlife Health. 2019;10:75–80.PubMedPubMedCentral
2.
go back to reference Munro MG, Critchley HO, Fraser IS. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them. Am J Obstet Gynecol. 2012;207:259–65.CrossRef Munro MG, Critchley HO, Fraser IS. The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them. Am J Obstet Gynecol. 2012;207:259–65.CrossRef
3.
go back to reference Fraser IS, Critchley HO, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29:383–90.CrossRef Fraser IS, Critchley HO, Broder M, et al. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29:383–90.CrossRef
4.
go back to reference Munro MG, Critchley HO, Fraser IS, et al. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011; 95:2204–8, 2208.e1–3. Munro MG, Critchley HO, Fraser IS, et al. The FIGO classification of causes of abnormal uterine bleeding in the reproductive years. Fertil Steril 2011; 95:2204–8, 2208.e1–3.
5.
go back to reference Fraser IS, Hickey M, Song JY. A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception. Hum Reprod. 1996;11(Suppl 2):165–78.CrossRef Fraser IS, Hickey M, Song JY. A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception. Hum Reprod. 1996;11(Suppl 2):165–78.CrossRef
6.
go back to reference Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016;34:54–65.CrossRef Whitaker L, Critchley HO. Abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol. 2016;34:54–65.CrossRef
7.
go back to reference Soleymani E, Ziari K, Rahmani O, et al. Histopathological findings of endometrial specimens in abnormal uterine bleeding. Arch Gynecol Obstet. 2014;289:845–9.CrossRef Soleymani E, Ziari K, Rahmani O, et al. Histopathological findings of endometrial specimens in abnormal uterine bleeding. Arch Gynecol Obstet. 2014;289:845–9.CrossRef
8.
go back to reference Bryant-Smith AC, Lethaby A, Farquhar C, Hickey M. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2018;4(4):CD000249. Bryant-Smith AC, Lethaby A, Farquhar C, Hickey M. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2018;4(4):CD000249.
9.
go back to reference Altmäe S, Esteban FJ, Stavreus-Evers A, et al. Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium. Hum Reprod Update. 2014;20:12–28.CrossRef Altmäe S, Esteban FJ, Stavreus-Evers A, et al. Guidelines for the design, analysis and interpretation of 'omics' data: focus on human endometrium. Hum Reprod Update. 2014;20:12–28.CrossRef
10.
go back to reference Srivastava S, Srivastava RG. Proteomics in the forefront of cancer biomarker discovery. J Proteome Res. 2005;4:1098–103.CrossRef Srivastava S, Srivastava RG. Proteomics in the forefront of cancer biomarker discovery. J Proteome Res. 2005;4:1098–103.CrossRef
11.
go back to reference Meehan KL, Rainczuk A, Salamonsen LA, et al. Proteomics and the search for biomarkers of female reproductive diseases. Reproduction. 2010;140:505–19.CrossRef Meehan KL, Rainczuk A, Salamonsen LA, et al. Proteomics and the search for biomarkers of female reproductive diseases. Reproduction. 2010;140:505–19.CrossRef
12.
go back to reference Magnay JL, O'Brien S, Gerlinger C, et al. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Womens Health. 2020;20:24.CrossRef Magnay JL, O'Brien S, Gerlinger C, et al. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Womens Health. 2020;20:24.CrossRef
13.
go back to reference Wiśniewski JR, Nagaraj N, Zougman A, et al. Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J Proteome Res. 2010;9:3280–9.CrossRef Wiśniewski JR, Nagaraj N, Zougman A, et al. Brain phosphoproteome obtained by a FASP-based method reveals plasma membrane protein topology. J Proteome Res. 2010;9:3280–9.CrossRef
14.
go back to reference Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37:1–13. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009; 37:1–13.
15.
go back to reference Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.CrossRef Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.CrossRef
16.
go back to reference Brlek P, Bukovac A, Kafka A, et al. TWIST1 upregulation affects E-cadherin expression in brain metastases. Clin Transl Oncol. 2020. Brlek P, Bukovac A, Kafka A, et al. TWIST1 upregulation affects E-cadherin expression in brain metastases. Clin Transl Oncol. 2020.
17.
go back to reference Singh S, Best C, Dunn S, et al. No. 292-abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2018;40:e391–415.CrossRef Singh S, Best C, Dunn S, et al. No. 292-abnormal uterine bleeding in pre-menopausal women. J Obstet Gynaecol Can. 2018;40:e391–415.CrossRef
18.
go back to reference Munro MG, Critchley HO, Fraser IS. The flexible FIGO classification concept for underlying causes of abnormal uterine bleeding. Semin Reprod Med. 2011;29:391–9.CrossRef Munro MG, Critchley HO, Fraser IS. The flexible FIGO classification concept for underlying causes of abnormal uterine bleeding. Semin Reprod Med. 2011;29:391–9.CrossRef
19.
go back to reference Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(4):CD000249. Lethaby A, Farquhar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev. 2000;(4):CD000249.
20.
go back to reference Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia. Am J Obstet Gynecol. 2004;190:1224–9.CrossRef Warner PE, Critchley HO, Lumsden MA, et al. Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia. Am J Obstet Gynecol. 2004;190:1224–9.CrossRef
21.
go back to reference Zhang Y, Yi F, Wang L, et al. Phosphorylation of SMC1A promotes hepatocellular carcinoma cell proliferation and migration. Int J Biol Sci. 2018;14:1081–9.CrossRef Zhang Y, Yi F, Wang L, et al. Phosphorylation of SMC1A promotes hepatocellular carcinoma cell proliferation and migration. Int J Biol Sci. 2018;14:1081–9.CrossRef
22.
23.
go back to reference Gargett CE, Ye L. Endometrial reconstruction from stem cells. Fertil Steril. 2012;98:11–20.CrossRef Gargett CE, Ye L. Endometrial reconstruction from stem cells. Fertil Steril. 2012;98:11–20.CrossRef
24.
go back to reference Li J, Feng W, Chen L, et al. Downregulation of SMC1A inhibits growth and increases apoptosis and chemosensitivity of colorectal cancer cells. J Int Med Res. 2016;44:67–74.CrossRef Li J, Feng W, Chen L, et al. Downregulation of SMC1A inhibits growth and increases apoptosis and chemosensitivity of colorectal cancer cells. J Int Med Res. 2016;44:67–74.CrossRef
25.
go back to reference Yadav S, Kowolik CM, Lin M, et al. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties. Mol Carcinog. 2019;58:113–25.CrossRef Yadav S, Kowolik CM, Lin M, et al. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties. Mol Carcinog. 2019;58:113–25.CrossRef
26.
go back to reference Pan XW, Gan SS, Ye JQ, et al. SMC1A promotes growth and migration of prostate cancer in vitro and in vivo. Int J Oncol. 2016;49:1963–72.CrossRef Pan XW, Gan SS, Ye JQ, et al. SMC1A promotes growth and migration of prostate cancer in vitro and in vivo. Int J Oncol. 2016;49:1963–72.CrossRef
27.
go back to reference Li J, He J, Wang Y, et al. SMC1 promotes proliferation and inhibits apoptosis through the NF-κB signaling pathway in colorectal cancer. Oncol Rep. 2019. Li J, He J, Wang Y, et al. SMC1 promotes proliferation and inhibits apoptosis through the NF-κB signaling pathway in colorectal cancer. Oncol Rep. 2019.
28.
go back to reference Sarogni P, Palumbo O, Servadio A, et al. Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development. J Exp Clin Cancer Res. 2019;38:108.CrossRef Sarogni P, Palumbo O, Servadio A, et al. Overexpression of the cohesin-core subunit SMC1A contributes to colorectal cancer development. J Exp Clin Cancer Res. 2019;38:108.CrossRef
Metadata
Title
Label-free proteomics uncovers SMC1A expression is Down-regulated in AUB-E
Authors
Yingxian Jia
Jie Luo
Yibing Lan
Chunming Li
Linjuan Ma
Xiaoming Zhu
Fei Ruan
Jianhong Zhou
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2021
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-021-00713-4

Other articles of this Issue 1/2021

Reproductive Biology and Endocrinology 1/2021 Go to the issue